 Having successfully concluded an independent in-vitro laboratory study and published the positive results earlier this year, the operational effectiveness of Microbot Medical Inc.s MBOT Self-Cleaning Shunt SCSTM was validated in a broader follow-up in-vitro lab study and clearly demonstrated the devices capability to prevent shunt occlusion under the parameters of that study. As a reminder, Mr. Gadot is presenting at the Rodman Renshaw Global Investment Conference today at 12:05 pm ET, at the Lotte New York Palace in New York City, where he will share the summary results of the follow-up in-vitro laboratory study as well demonstrating a working headset prototype of the SCSTM device. 